ORASURE TECHNOLOGIES, INC (OSUR) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
50/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinOSUR / S&P 48.67% / 15.20% |
LoseOSUR / S&P -18.86% / 15.00% |
LoseOSUR / S&P 2.99% / 50.40% |
| 2026-Q12/3 |
WinOSUR / S&P 23.97% / -4.33% |
LoseOSUR / S&P -30.08% / 11.30% |
WinOSUR / S&P 147.62% / 27.70% |
| 2025-Q41/3 |
LoseOSUR / S&P -24.61% / 2.65% |
LoseOSUR / S&P -38.10% / 9.00% |
WinOSUR / S&P 257.69% / 13.40% |
| 2025-Q30/3 |
LoseOSUR / S&P 7.00% / 8.12% |
LoseOSUR / S&P -43.95% / 4.61% |
LoseOSUR / S&P -633.33% / 13.45% |
| 2025-Q20/3 |
LoseOSUR / S&P -10.98% / 10.94% |
LoseOSUR / S&P -49.35% / 4.83% |
LoseOSUR / S&P -286.11% / 10.63% |
| 2025-Q10/3 |
LoseOSUR / S&P -6.65% / -4.27% |
LoseOSUR / S&P -46.95% / 4.98% |
LoseOSUR / S&P -240.00% / 10.57% |
| 2024-Q40/3 |
LoseOSUR / S&P -15.46% / 2.41% |
LoseOSUR / S&P -54.17% / 5.25% |
LoseOSUR / S&P -136.11% / 6.15% |
| 2024-Q30/3 |
LoseOSUR / S&P 0.23% / 5.89% |
LoseOSUR / S&P -50.46% / 5.89% |
LoseOSUR / S&P -77.27% / 6.11% |
| 2024-Q20/3 |
LoseOSUR / S&P -30.73% / 4.28% |
LoseOSUR / S&P -43.01% / 5.38% |
LoseOSUR / S&P -38.98% / 5.12% |
| 2024-Q10/3 |
LoseOSUR / S&P -25.00% / 10.56% |
LoseOSUR / S&P -35.83% / 5.71% |
LoseOSUR / S&P -25.00% / 5.59% |
| 2023-Q41/3 |
WinOSUR / S&P 38.28% / 11.69% |
LoseOSUR / S&P 4.64% / 6.81% |
LoseOSUR / S&P -388.00% / 7.78% |
| 2023-Q32/3 |
WinOSUR / S&P 18.36% / -3.27% |
WinOSUR / S&P 38.02% / 7.52% |
LoseOSUR / S&P -210.00% / -5.03% |
| 2023-Q21/3 |
LoseOSUR / S&P -17.19% / 8.74% |
WinOSUR / S&P 80.82% / 9.50% |
LoseOSUR / S&P -166.29% / -8.57% |
| 2023-Q12/3 |
WinOSUR / S&P 25.52% / 7.50% |
WinOSUR / S&P 95.53% / 10.77% |
LoseOSUR / S&P -161.54% / -15.69% |
| 2022-Q42/3 |
WinOSUR / S&P 27.18% / 7.56% |
WinOSUR / S&P 65.82% / 11.88% |
LoseOSUR / S&P -21.88% / -17.99% |
| 2022-Q32/3 |
WinOSUR / S&P 39.85% / -4.88% |
WinOSUR / S&P 40.78% / 13.47% |
LoseOSUR / S&P -306.90% / -1.41% |
| 2022-Q21/3 |
LoseOSUR / S&P -60.03% / -16.10% |
WinOSUR / S&P 16.90% / 13.71% |
LoseOSUR / S&P -274.51% / 11.04% |
| 2022-Q11/3 |
LoseOSUR / S&P -21.98% / -4.60% |
WinOSUR / S&P 22.19% / 15.97% |
LoseOSUR / S&P -275.68% / 42.23% |
| 2021-Q41/3 |
LoseOSUR / S&P -23.17% / 11.03% |
WinOSUR / S&P 36.08% / 15.00% |
LoseOSUR / S&P -260.00% / 96.40% |
| 2021-Q32/3 |
WinOSUR / S&P 11.54% / 0.58% |
WinOSUR / S&P 46.95% / 10.77% |
LoseOSUR / S&P -226.09% / 69.42% |
| 2021-Q21/3 |
LoseOSUR / S&P -13.11% / 8.55% |
WinOSUR / S&P 54.97% / 6.58% |
LoseOSUR / S&P -1800.00% / 51.81% |
| 2021-Q13/3 |
WinOSUR / S&P 10.20% / 6.17% |
WinOSUR / S&P 27.31% / -1.06% |
WinOSUR / S&P 85.00% / 7.39% |
| 2020-Q42/3 |
LoseOSUR / S&P -12.98% / 12.15% |
WinOSUR / S&P 11.07% / -3.72% |
WinOSUR / S&P -25.93% / -33.42% |
| 2020-Q31/3 |
LoseOSUR / S&P 4.64% / 8.93% |
WinOSUR / S&P 2.16% / -2.04% |
LoseOSUR / S&P -157.50% / -27.10% |
| 2020-Q20/3 |
LoseOSUR / S&P 8.09% / 20.54% |
LoseOSUR / S&P -11.25% / -0.46% |
LoseOSUR / S&P -109.38% / -27.11% |
| 2020-Q11/3 |
WinOSUR / S&P 34.00% / -19.60% |
LoseOSUR / S&P -8.12% / 3.47% |
LoseOSUR / S&P -37.50% / -14.75% |
| 2019-Q40/3 |
LoseOSUR / S&P 7.50% / 9.07% |
LoseOSUR / S&P -14.93% / 5.36% |
LoseOSUR / S&P -20.59% / 2.99% |
| 2019-Q31/3 |
LoseOSUR / S&P -19.50% / 1.70% |
LoseOSUR / S&P -15.44% / 5.02% |
WinOSUR / S&P 37.93% / 0.21% |
| 2019-Q21/3 |
LoseOSUR / S&P -16.77% / 4.30% |
LoseOSUR / S&P -8.27% / 6.64% |
WinOSUR / S&P 28.00% / 8.65% |
| 2019-Q11/3 |
LoseOSUR / S&P -4.54% / 13.65% |
LoseOSUR / S&P -3.75% / 8.12% |
WinOSUR / S&P 18.52% / 14.29% |
| 2018-Q40/3 |
LoseOSUR / S&P -24.40% / -13.52% |
LoseOSUR / S&P 8.79% / 9.05% |
LoseOSUR / S&P -33.33% / 18.23% |
| 2018-Q31/3 |
LoseOSUR / S&P -6.19% / 7.71% |
WinOSUR / S&P 21.92% / 10.21% |
LoseOSUR / S&P -44.23% / 19.06% |
| 2018-Q21/3 |
LoseOSUR / S&P -2.49% / 3.43% |
WinOSUR / S&P 28.11% / 9.03% |
LoseOSUR / S&P -53.70% / 14.46% |
| 2018-Q11/3 |
LoseOSUR / S&P -10.45% / -0.76% |
WinOSUR / S&P 34.07% / 7.68% |
LoseOSUR / S&P -48.08% / 12.46% |
| 2017-Q42/3 |
LoseOSUR / S&P -16.18% / 6.64% |
WinOSUR / S&P 30.32% / 7.03% |
WinOSUR / S&P 45.71% / 13.82% |
| 2017-Q33/3 |
WinOSUR / S&P 30.36% / 4.48% |
WinOSUR / S&P 20.35% / 5.68% |
WinOSUR / S&P 73.33% / 17.57% |
| 2017-Q23/3 |
WinOSUR / S&P 33.49% / 3.09% |
WinOSUR / S&P 14.49% / 4.83% |
WinOSUR / S&P 145.45% / 17.74% |
| 2017-Q13/3 |
WinOSUR / S&P 47.27% / 6.07% |
WinOSUR / S&P 8.16% / 3.67% |
WinOSUR / S&P 188.89% / 13.32% |
| 2016-Q43/3 |
WinOSUR / S&P 10.16% / 3.82% |
WinOSUR / S&P 7.08% / 2.09% |
WinOSUR / S&P 150.00% / 7.05% |
| 2016-Q33/3 |
WinOSUR / S&P 34.86% / 3.85% |
WinOSUR / S&P 7.81% / 0.20% |
WinOSUR / S&P 1400.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | OSUR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 11.48% | 20.78% |
| Annualized return | 11.48% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | OSUR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -66.99% | 83.14% |
| Annualized return | -19.88% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | OSUR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -56.89% | 319.30% |
| Annualized return | -8.07% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |